Clinical Trial Update: A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating idebenone versus placebo in prodromal Parkinson disease and REM sleep behavior disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Rem Sleep Behavior Disorder

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: REM Sleep Behavior Disorder, Parkinson Disease | Phase 2, Phase 3 | Status: WITHDRAWN